RhumbLine Advisers’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-75,155
Closed -$259K 3123
2021
Q1
$259K Sell
75,155
-2,420
-3% -$8.34K ﹤0.01% 2750
2020
Q4
$195K Buy
77,575
+9,309
+14% +$23.4K ﹤0.01% 2847
2020
Q3
$144K Sell
68,266
-9,438
-12% -$19.9K ﹤0.01% 2784
2020
Q2
$174K Buy
77,704
+5,960
+8% +$13.3K ﹤0.01% 2819
2020
Q1
$182K Hold
71,744
﹤0.01% 2619
2019
Q4
$189K Sell
71,744
-261
-0.4% -$688 ﹤0.01% 2765
2019
Q3
$259K Buy
72,005
+5,715
+9% +$20.6K ﹤0.01% 2640
2019
Q2
$223K Buy
66,290
+6,903
+12% +$23.2K ﹤0.01% 2746
2019
Q1
$162K Sell
59,387
-1,155
-2% -$3.15K ﹤0.01% 2794
2018
Q4
$168K Buy
60,542
+19,181
+46% +$53.2K ﹤0.01% 2786
2018
Q3
$170K Sell
41,361
-2,850
-6% -$11.7K ﹤0.01% 2779
2018
Q2
$229K Buy
44,211
+3,955
+10% +$20.5K ﹤0.01% 2675
2018
Q1
$221K Sell
40,256
-1,075
-3% -$5.9K ﹤0.01% 2569
2017
Q4
$337K Sell
41,331
-8,446
-17% -$68.9K ﹤0.01% 2406
2017
Q3
$521K Buy
49,777
+525
+1% +$5.5K ﹤0.01% 2290
2017
Q2
$544K Buy
49,252
+4,720
+11% +$52.1K ﹤0.01% 2251
2017
Q1
$373K Buy
44,532
+1,762
+4% +$14.8K ﹤0.01% 2395
2016
Q4
$297K Buy
42,770
+2,785
+7% +$19.3K ﹤0.01% 2500
2016
Q3
$204K Buy
39,985
+1,000
+3% +$5.1K ﹤0.01% 2670
2016
Q2
$233K Buy
+38,985
New +$233K ﹤0.01% 2663
2015
Q2
Sell
-35,115
Closed -$104K 3094
2015
Q1
$104K Buy
35,115
+6,800
+24% +$20.1K ﹤0.01% 2950
2014
Q4
$126K Buy
28,315
+825
+3% +$3.67K ﹤0.01% 2932
2014
Q3
$142K Hold
27,490
﹤0.01% 2871
2014
Q2
$144K Buy
+27,490
New +$144K ﹤0.01% 2929